Evidence map›Paper›PMID 29298914›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Atomic mutagenesis of stop codon nucleotides reveals the chemical prerequisites for release factor-mediated peptide release.

Thomas Philipp Hoernes, Nina Clementi, Michael Andreas Juen, Xinying Shi, Klaus Faserl, Jessica Willi, Catherina Gasser, Christoph Kreutz, Simpson Joseph, Herbert Lindner and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Calculated pThe journal of physical chemistry. A · 2023
    Article
  5. Review
  6. Synthesis of point-modified mRNA.Nucleic acids research · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Thomas Philipp HoernesDivision of Genomics and RNomics, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-9523-2514
Nina ClementiDivision of Genomics and RNomics, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Michael Andreas JuenInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, 6020 Innsbruck, Austria.
Xinying ShiDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093-0314.
Klaus FaserlDivision of Clinical Biochemistry, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Jessica WilliDepartment of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland.
Catherina GasserInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, 6020 Innsbruck, Austria.
Christoph KreutzInstitute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, 6020 Innsbruck, Austria.
Simpson JosephDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093-0314.
Herbert LindnerDivision of Clinical Biochemistry, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Alexander HüttenhoferDivision of Genomics and RNomics, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Matthias David ErlacherDivision of Genomics and RNomics, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria; matthias.erlacher@i-med.ac.at.ORCID 0000-0001-5570-9437
Innsbruck Medical University · ATUniversität Innsbruck · ATUniversity of California San Diego · USUniversity of Bern · CH

Funding

Austrian Science Fund FWF P 22658
6 · The paper itself

Abstract

Termination of protein synthesis is triggered by the recognition of a stop codon at the ribosomal A site and is mediated by class I release factors (RFs). Whereas in bacteria, RF1 and RF2 promote termination at UAA/UAG and UAA/UGA stop codons, respectively, eukaryotes only depend on one RF (eRF1) to initiate peptide release at all three stop codons. Based on several structural as well as biochemical studies, interactions between mRNA, tRNA, and rRNA have been proposed to be required for stop codon recognition. In this study, the influence of these interactions was investigated by using chemically modified stop codons. Single functional groups within stop codon nucleotides were substituted to weaken or completely eliminate specific interactions between the respective mRNA and RFs. Our findings provide detailed insight into the recognition mode of bacterial and eukaryotic RFs, thereby revealing the chemical groups of nucleotides that define the identity of stop codons and provide the means to discriminate against noncognate stop codons or UGG sense codons.

Indexed as

Codon, TerminatorEscherichia coliEscherichia coli ProteinsMutagenesis, Site-DirectedNucleotidesPeptide Chain Termination, TranslationalPeptide Termination FactorsProtein BiosynthesisCodon, TerminatorEscherichia coli ProteinsNucleotidesPeptide Termination FactorsmRNA modificationpeptide releaserelease factorribosometranslation

Identifiers

PMID29298914
PMCPMC5776981
OpenAlexW2781829910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.